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Objective/Background: Tuberculosis (TB) remains one of the deadliest infectious diseases
worldwide, with a disproportionate number of those affected living in slum areas. We
assessed the magnitude of pulmonary cases among tuberculosis patients in an urban slum
in southeast Nigeria, their demographic and clinical characteristics and any associations
with treatment outcomes.
Methods: A retrospective cohort study of patients registered under the National TB Pro-
gramme (NTP) from 1 January to 31 December 2012 was carried out. Data were extracted
from TB treatment cards and registers.
Results: Of 647 new TB patients registered, 555 (85.8%) were pulmonary TB (PTB) with a
mean age of 34.5 years, and a male/female ratio of 1.3. Among these, 468 (84.3%) were
smear-positive, while 87 (15.7%) were smear-negative cases. Twenty-one (3.8%) were
children younger than 15 years old. TB/HIV co-infection rate was 16.9%; 57.4% received
antiretroviral therapy (ART) and 88.3% received cotrimoxazole preventive therapy (CPT).
Female patients were significantly younger compared to male patients (p = 0.003), had
higher proportions of smear-negative TB (p = 0.001) and HIV-positive status (p 6 0.001).
Treatment success rate was 88.5% among smear-positive patients and 79.3% among
smear-negative patients. More patients with smear-negative TB were lost to follow up
compared with smear-positive TB patients (p < 0.02). HIV co-infection was associated with
unfavourable treatment outcomes (OR 0.2, CI 0.1–0.4, p 6 0.001). Among them, those who
received ART had better outcomes.
Conclusions: The study revealed high proportion of PTB, mostly smear-positive TB with
HIV-associated outcomes and underlines the need to ensure early TB diagnosis and
improved access to HIV care for HIV co-infected patients in this setting.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.
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Nigeria remains one of the countries with the highest tuber-
culosis (TB) burden in the world. According to the 2014 Global
TB Control Report, the burden of TB is estimated at 338 per
100,000 population in the form of incidence and 322 per
100,000 population in the form of prevalence [1]. The National
TB Programme (NTP) was established in 1991 and adopted the
World Health Organization (WHO) recommended DOTS
strategy in 1993. TB case-detection rate, which continues to
show a rising trend, stagnated at 51% in 2012. The 2012
national survey of TB prevalence showed that only one out
of every five active TB cases in the communities was notified
by the NTP [2].
In many countries, disparities in TB incidence within pop-
ulations have been described [3]. In urban areas, TB occurs
mainly among risk groups, such as slum populations who
are predisposed to poor living and environmental conditions
[3–5]. However, TB patients in urban slums are rarely
evaluated by NTPs in sub-Saharan Africa despite the
pervasiveness of urban slums in recent years [6]. The accurate
measure of the burden of TB in urban slums is difficult to
obtain, mainly due to under-reporting and/or non-inclusion
of sub-population data in national routine surveillance
systems. In 2012, 5.7 million newly diagnosed cases of TB
were notified by NTPs worldwide; 360,000 of whom were
HIV positive [1]. Approximately 37% were estimated to occur
among slum populations. In countries with high TB burden,
slum populations account for 45–50% of all TB cases [7,8]. This
proportion is, however, less in countries with a low TB
burden.
In Nigeria, information on the burden of TB in slum popu-
lations is limited, especially in relation to epidemiological
characteristics and their associations with treatment
outcomes. Such information, however, would be valuable in
contributing to robust measurement and understanding of
the national burden of TB disease. The Nigerian national
routine surveillance system commonly captures information
on TB registration for all patient categories within the general
population, however, such information is not available at
sub-population levels including high-risk groups, such as
slum populations. This study aims to assess the magnitude
of pulmonary cases among tuberculosis patients in an urban
slum in southeast Nigeria, their demographic and clinical char-
acteristics and any associations with treatment outcomes.Materials and methods
Study design
This was a retrospective cohort study involving a review of TB
treatment cards and registers maintained under the NTP
surveillance system in Aba, Abia State, Nigeria, from January
1, 2012 to December 31, 2012.
Study setting—description
The study was conducted at a low-income densely populated
urban slum (Aba) located in Abia State. Aba has a projectedpopulation of 619,583 [9] and is regarded as the most densely
populated urban slum in Nigeria [10] with a population den-
sity estimated at 49.78 persons/hectare. It is comprised
mostly of a heterogeneous group of people, dump-sites and
displaced populations, majority of who are living in unstruc-
tured temporary settlements. TB services (diagnosis and
treatment) are integrated within the public health system
and are managed by the state ministry of health under the
NTP. There are five public health centres in Aba. The state
ministry of health also collaborates with six private health
facilities located within the slum for the provision of TB
services in the context of public–private partnership. All
public and private health facilities providing TB services in
Aba participated in the study.Diagnosis and management of TB
Diagnosis and management of TB was based on the NTP
guidelines [11]. A person coughing for 2 weeks or more with
or without other clinical presentation was identified as
pulmonary TB suspect and requested by a health worker to
provide three sputum samples (spot, morning, and spot) for
acid-fast bacilli microscopy. Pulmonary smear positive TB
was defined as a positive sputum smear for AFB (acid-fast
bacilli) confirmed with one or more positive smears.
Pulmonary smear negative was defined by negative smear
for AFB with radiological, clinical, and/or histological
findings consistent with active TB followed by the deci-
sion by a clinician to treat with a full course of TB
chemotherapy.
Anti-TB treatment was based on the use of directly
observed treatment (DOT), short course chemotherapy for a
duration of 8 months (2 months intensive phase and
6 months continuation phase). During the intensive phase,
treatment was given daily under the direct observation of a
trained health worker or a trained treatment supporter. For
the continuation phase, treatment was given monthly and
self-administered. Both smear-positive and smear-negative
TB patients were treated with the same standardised
first-line antituberculosis regimen consisting of rifampicin
(R), isoniazid (H), pyrazinamide (Z), and ethambutol (E) in
accordance with the NTP guidelines. HIV counselling and
testing was offered to all patients, and those who were found
to be HIV positive were referred for HIV care and support—
antiretroviral therapy (ART) and cotrimoxazole preventive
therapy (CPT). Diagnosis and treatment details of TB patients
were recorded in routine standard NTP TB treatment cards
and registers.Data collection
All health facilities providing TB services within the slum area
were visited by two trained researchers. Relevant data of all
new TB patients registered from January 1, 2012 to December
31, 2012 were extracted from the NTP TB treatment cards and
registers into a data-collection form designed for this study. Vari-
ables recorded included TB registration number, gender, age,
HIV status, type of TB, treatment duration, and treatment
outcome.
Table 1 – Demographic and clinical characteristics of
patients with new pulmonary TB registered in 2012
(n = 555).
Category n (%)
Gender
Female 239 (43.1)
Male 316 (56.9)
Age group (years)
0–14 21 (3.8)
15–24 91 (16.4)
25–34 162 (29.2)
35–44 128 (23.1)
45–54 86 (15.5)
55–64 34 (6.1)
P65 33 (5.9)
Patients type
New smear-positive 468 (84.3)
New smear-negative 87 (15.7)
HIV status
Positive 94 (16.9)
Negative 461 (83.1)
HIV positive (n = 94)
On CPT 83 (88.3)
On ART 54 (57.4)
Note: ART = antiretroviral therapy; CPT = cotrimoxazole preventive
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Data were double-entered into a Excel 2013 (Microsoft Corpo-
ration, Redmond, WA) database by two independent data
operators, and validated for inconsistencies. In case of
disparities, information on the original data-collection tool
was verified. Data analyses were performed using the Statis-
tical Package for Social Sciences (SPSS) version 20.0 (IBM Corp,
Armonk, NY, USA). For the purpose of this analysis, treatment
outcomes were categorised as favourable (cured and treat-
ment completed) and unfavourable (lost to follow-up, died,
treatment failure, and transferred out). Demographic and
clinical characteristics were described in terms of frequencies
and percentages. The chi-square test, odds ratios (OR) and
95% confidence intervals (95% CI) were used to compare
groups as appropriate. Levels of significance were set at 5%.
Ethical issues
This study was based on review of existing records without
involving patient interaction, hence, informed consent was
deemed not necessary. Ethical clearance was obtained from
the Ethics Committee of the Abia State University Teaching
Hospital, Abia State, Nigeria. Institutional approval was
obtained from the state TB control programme.therapy; NTP = National Tuberculosis Control Programme;
TB = tuberculosis.
Results
Of 647 new TB cases registered under the NTP from January 1,
2012 to December 31, 2012, 555 (85.8%) were pulmonary TB
(PTB) cases with amean age of 34.5 years andmale/female ratio
of 1.3. Among these, 468 (84.3%) were smear-positive TB and 87
(15.7%) smear-negative TB cases (Table 1). There were 21 (3.8%)
children aged 0–14 years. The proportion of pulmonary TB cases
was highest (29.2%) among the 25–34 year age group. TB/HIV
co-infection rate was 16.9% (n = 94). Of these, 57.4% (n = 54)
received ART and 88.3% (n = 83) received CPT.
Table 2 shows the characteristics of patients registered
and disaggregation by gender. Female patients were signifi-
cantly younger compared to male patients (p = 0.003), had
higher proportions of smear-negative TB (p = 0.001) and
HIV-positive status (p 6 0.001).
Treatment outcomes of smear-positive PTB patients and
smear-negative PTB patients registered are shown in Table 3.
Of 468 smear-positive PTB patients evaluated, 88.5% (n = 414)
successfully completed treatment, 26 (5.6) died, 18 (3.8) were
lost to follow-up, 9 (1.9) failed treatment and 1 (0.2) was trans-
ferred out. Among 85 smear-negative PTB patients evaluated,
79.3% (n = 65) successfully completed treatment, 5 (5.7) died,
and 13 (14.9) were lost to follow-up. There were more patients
with smear-negative PTB who were lost to follow-up
compared with smear-positive PTB (p < 0.02). In Table 4, treat-
ment outcomes were assessed in relation to demographic
characteristics, sites of disease, HIV status, and ART use for
HIV-positive patients. HIV co-infected patients had a higher
risk of unfavourable outcomes than HIV-negative PTB
patients during treatment (OR 0.2, CI 0.1–0.4, p 6 0.001).
Among them, TB treatment outcomes were much better
among those who received ART (p < 0.001).Discussion
In this study of the magnitude, profile, and treatment out-
comes among pulmonary TB patients in an urban slum, we
found that more than 85% of all new TB cases registered were
pulmonary TB, mostly smear-positive TB and over half were
aged 25–44 years. Female patients were significantly younger
compared to male patients, had a higher proportion of
smear-negative TB and HIV-positive status. Although treat-
ment outcomes were better among smear-positive than
smear-negative TB patients, HIV-positive status was associ-
ated with unfavourable outcomes.
The measured proportion of pulmonary smear-positive TB
cases in the study population was high, almost 30% higher
than the national average. This is in line with the findings
described in previous studies in Bangladesh and India
[12,13] but higher than the rate reported among chronic
coughers in Uganda, which revealed a proportion of 55%
[14]. These large numbers of pulmonary smear-positive TB
cases indicate the high concentration of TB and underlying
transmission in the slum areas. In sub-Saharan Africa, the
situation is further complicated by a HIV epidemic which is
currently running at a median prevalence of 3.4% [15] in
Nigeria. The Nigerian NTP implements the WHO recom-
mended DOTS strategy and its policy guidelines rely heavily
on passive case-finding and use of sputum smear microscopy
and chest X-ray findings for diagnosis of TB. Additional strate-
gies complementing facility-based interventions that will
involve systematically identifying potentially infectious indi-
Table 2 – Demographic and clinical characteristics of patients disaggregated by gender (n = 555).
Variables Total, n (%) Male, n (%) Female, n (%) OR (95%CI) p Value
Age (years)
<15 21 (3.8) 6 (1.8) 15 (6.8) 0.2 (0.1–0.6) 0.003
P15 534 (96.2) 329 (98.2) 205 (93.2) Reference
Patient type
New smear-positive 468 (84.3) 285 (90.2) 193 (80.8) Reference
New smear-negative 87 (15.7) 31 (9.8) 46 (19.2) 0.4 (0.2–0.7) 0.001
HIV status
Positive 94 (16.9) 38 (12.0) 56 (23.4) 0.4 (0.2–0.7) 0.000
Negative 461 (83.1) 278 (88.0) 183 (76.6) Reference
ART use (n = 94)
Yes 54 (57.4) 20 (52.6) 34 (60.7) Reference
No 40 (42.6) 18 (47.4) 22 (39.3) 1.3 (0.6–3.0) 0.44
CPT use (n = 94)
Yes 83 (88.3) 31 (81.6) 52 (92.9) Reference
No 11 (11.7) 7 (18.4) 4 (7.1) 2.9 (0.7–10.8) 0.11
Note: CI = confidence interval; NTP = National Tuberculosis Control Programme; OR = odds ratio; TB = tuberculosis.
Table 4 – Comparison of demographic and clinical characteristics and treatment outcomes of TB cases registered under the
NTP in 2012.
Category Favourable outcome, n (%) Unfavourable outcome, n (%) OR (95% CI) p Value
Gender
Female 194 (81.2) 45 (18.8) 0.6 (0.4–1.0) 0.07
Male 274 (89.9) 42 (10.1) Reference
Age group (years)
<15 20 (95.2) 1 (4.8) Reference
P15 448 (83.9) 86 (16.1) 0.2 (0.0–1.9) 0.15
HIV status
Positive 67 (71.3) 27 (28.7) 0.2 (0.1–0.4 <0.001
Negative 416 (90.2) 45 (9.8) Reference
HIV Positive on ART
Yes 46 (85.2) 8 (14.8) 0.1 (0.0–0.5) <0.001
No 21 (52.5) 19 (47.5) Reference
Note: CI = confidence interval; Favourable outcome = cured and treatment completed; NTP = National Tuberculosis Control Programme;
OR = Odds ratio; TB = tuberculosis; Unfavourable outcome = defaulted, died, failure, or transferred out.
Table 3 – Treatment outcomes of new pulmonary TB patients registered under the NTP in 2012.
Treatment outcomes Sm+, n (%) Sm–, n (%) p Value
Treatment success 414 (88.5) 65 (79.3) 0.74
Died 26 (5.6) 5 (5.7) NS
Lost to follow-up 18 (3.8) 13 (14.9) 0.02
Failure 9 (1.9) 0 (0.0) 0.25
Transferred out 1 (0.2) 0 (0.0) 0.84
Total evaluated 468 (100.0) 87 (100.0)
Note: NS = not significant; NTP = National Tuberculosis Control Programme; Sm+= smear-positive; Sm– = smear-negative; TB = tuberculosis.
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early entry into TB care are clearly needed.
The age-specific distribution of TB showed that TB was
most common among the 25–44 year age group. This finding
is consistent with results of similar studies in some high TB
burden countries, like Bangladesh, Kenya, and India [16–18].In contrast, in Vietnam, China, and Cambodia, the age group
most affected was 65 years and older followed by the
45–54 year age group [19]. The reason for these differences is
not clear, though it may be due to difference in the levels of
economic and demographic transmission occurring in these
populations. A male–female ratio of 1.3 appears a common
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age–gender distribution shows that there were larger propor-
tion of females among the childhood TB cases. The difference
in the gender distribution of TB may be due to the epidemio-
logic situation in the setting concerned. Previous studies have
shown that cultural factors leading to differences in access to
health services, behavioural, and biological mechanisms are
key reasons for susceptibility differences between men and
women [23].
Treatment outcomes were better among smear-positive
than smear-negative patients. The most striking unfavour-
able outcome among smear-negative TB patients was the lost
to follow-up rate. The measured proportion of treatment lost
to follow-up is more than those routinely reported for all TB
patients in the general population [24], indicating a poor
retrieval performance by the healthcare providers, and the
need to improve patient counselling before initiation of treat-
ment. Also, within the subgroups, HIV-positive patients had
significantly higher risk of unfavourable treatment outcomes
than HIV negative patients. There is therefore need to priori-
tise early case finding amongst this sub-group of patients by
the NTP. The NTP currently promotes TB/HIV collaborative
activities [11]. There is a need to strengthen the mechanisms
for collaboration and orient it towards effective case manage-
ment in the setting. The collaboration should give particular
attention to patient monitoring and modification of existing
referral and retrieval systems. Furthermore, 42.6% and
11.7% of HIV co-infected patients did not receive ART and
CPT, respectively. This finding calls for the combined
attention of the TB and HIV national programmes to optimise
supervision and access to HIV care for co-infected patients.
Among HIV co-infected patients, those who received ART
had much better treatment outcomes. Therefore, both
national programmes would benefit through more attention
on getting all HIV-infected TB patients on ART.
This study had some limitations. First, the study was
based on a review of routinely maintained data; thus valida-
tion of the records was difficult. However, the recording and
reporting system of the NTP is monitored every 3 months by
the National TB Control Programme staff, who systematically
review patients’ personal data and quarterly reports during
supervisory visits and make corrections if necessary. Second,
information about possible confounders other than those
investigated in this study was not available and thus could
not be assessed or adjusted to decide an association. Third,
selection of the study site was purposeful based on the area
of work of the principal investigator. However, the site is a
densely populated low-income urban slum settlement in
need of an effective health system. In addition, all public
and private health facilities providing TB services in the slum
area participated in the study.Conclusions
Overall, the study shows high proportion of pulmonary TB
cases in Aba, particularly smear-positive TB. Among them,
female patients were significantly younger compared to male
patients, had higher proportions of smear-negative TB and
HIV-positive status. Treatment outcomes were better amongsmear-positive compared to smear-negative TB patients. HIV
co-infected patients had significant risk of unfavourable
treatment outcomes compared to HIV-negative patients, how-
ever, those who received ART had much better outcomes. The
NTP would benefit from interventions that focus on active
case finding and increased access to HIV care for HIV co-
infected patients.Conflicts of interest
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